18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level

Nuclear Medicine Communications

Volumn 32, Issue 9, 2011, Pages 789-793

  Mittal, Bhagwant Rai ^a   Senthil, Raja ^a   Kashyap, Raghava ^a   Bhattacharya, Anish ^a   Singh, Baljinder ^a   Kapoor, Rakesh ^a   Gupta, Rajesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

18F fluorodeoxyglucose; Colorectal cancer; positron emission tomography computed tomography; recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; WHOLE BODY PET; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SYSTEM ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SYSTEMS INTEGRATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80051799985     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283477dd7     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66. (Pubitemid 46148091)
2. American Cancer Society. Cancer facts and figures 2010. Atlanta, GA: American Cancer Society, Surveillance and Health Policy Research; 2010.
3. Goldberg RM. Intensive surveillance after stage II or III colorectal cancer: is it worth it? J Clin Oncol 2006;24:330-331. (Pubitemid 46630448)
4. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection of colon cancer. Dis Colon Rectum 1997;40:15-24. (Pubitemid 27056393)
5. Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003;21:3623-3628. (Pubitemid 46594055)
6. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998;129:27-35. (Pubitemid 28304649)
7. Engstrom PF. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. National Comprehensive Cancer Network; 2007:2. Available at: http://www.nccn.org. [Accessed 28 January 2008].
8. Engstrom PF. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. National Comprehensive Cancer Network; 2007:1. Available at: http://www.nccn.org. [Accessed 28 January 2008].
9. Scott AM. Current status of positron emission tomography in oncology. Intern Med J 2001;31:27-36. (Pubitemid 32411162)
10. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000;41:1177-1189. (Pubitemid 30464000)
11. 18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996;131:703-707. (Pubitemid 26243630)
12. 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002;43:492-499. (Pubitemid 34286344)
13. Bipat S, Van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 2005;237:123-131. (Pubitemid 41346155)
14. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-1034.
15. Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 2007;17:2044-2054. (Pubitemid 47097462)
16. Veit-Haibach P, Kuehle CA, Beyer T, Stergar H, Kuehl H, Schmidt J. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 2006;296:2590-2600. (Pubitemid 44903862)
17. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-447.